Catalyst Wire Dossier Catalyst Wire Dossier

LNP023

iptacopan · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LNP023, covering 2022-07-08 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Managed Access Programs for LNP023, Iptacopan

See pricing